Alzheimer's Anti-Inflammation trial halted early – no breakthrough
NCT ID NCT04795466
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 25 times
Summary
This study tested whether anti-inflammatory drugs could help people with early Alzheimer's or mild cognitive impairment. The trial was stopped early, so only one drug was tested in 34 participants. The goal was to see if the drug improved thinking and memory, but the early end means we have limited results. This is not a cure, and more research is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Charlestown, Massachusetts, 02129, United States
-
Novartis Investigative Site
Kuopio, 70210, Finland
-
Novartis Investigative Site
Turku, 20520, Finland
-
Novartis Investigative Site
Reykjavik, 101, Iceland
-
Novartis Investigative Site
Plymouth, Devon, PL6 8BT, United Kingdom
-
Novartis Investigative Site
Guildford, Surrey, GU27YD, United Kingdom
-
Novartis Investigative Site
London, W1G 9JF, United Kingdom
-
Novartis Investigative Site
Motherwell, ML1 4UF, United Kingdom
-
Novartis Investigative Site
Southampton, SO30 3JB, United Kingdom
-
SUNY at Stony Brook
Stony Brook, New York, 11794-8161, United States
Conditions
Explore the condition pages connected to this study.